Advertisement
HIND vs IMMP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a StrongBuy and IMMP is a Hold.
HIND in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 05, 2026
HIND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 43 cases where HIND's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIND advanced for three days, in 139 of 174 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIND as a result. In 84 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HIND turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 36 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIND entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.833) is normal, around the industry mean (3.498). P/E Ratio (-0.981) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (108.696) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. HIND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
IMMP in +41.26% Uptrend, advancing for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IMMP advanced for three days, in 208 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMMP's RSI Indicator exited the oversold zone, 21 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IMMP as a result. In 69 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for IMMP just turned positive on October 20, 2026. Looking at past instances where IMMP's MACD turned positive, the stock continued to rise in 33 of 40 cases over the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMMP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
IMMP broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IMMP entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. IMMP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.999) is normal, around the industry mean (3.498). P/E Ratio (-0.310) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (4.627) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
HIND | IMMP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 61 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 82 | 65 | |
P/E GROWTH RATING 1..100 | 16 | 8 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HIND's Valuation (65) in the null industry is in the same range as IMMP (78) in the Biotechnology industry. This means that HIND’s stock grew similarly to IMMP’s over the last 12 months.
HIND's Profit vs Risk Rating (100) in the null industry is in the same range as IMMP (100) in the Biotechnology industry. This means that HIND’s stock grew similarly to IMMP’s over the last 12 months.
IMMP's SMR Rating (98) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that IMMP’s stock grew similarly to HIND’s over the last 12 months.
IMMP's Price Growth Rating (65) in the Biotechnology industry is in the same range as HIND (82) in the null industry. This means that IMMP’s stock grew similarly to HIND’s over the last 12 months.
IMMP's P/E Growth Rating (8) in the Biotechnology industry is in the same range as HIND (16) in the null industry. This means that IMMP’s stock grew similarly to HIND’s over the last 12 months.
| HIND | IMMP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 78% |
| Advances ODDS (%) | 13 days ago 80% | 3 days ago 83% |
| Declines ODDS (%) | 6 days ago 90% | 7 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HIND’s FA Score shows that 1 FA rating(s) are green while IMMP’s FA Score has 1 green FA rating(s).
- HIND’s FA Score: 1 green, 4 red.
- IMMP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HIND’s TA Score shows that 4 TA indicator(s) are bullish while IMMP’s TA Score has 4 bullish TA indicator(s).
- HIND’s TA Score: 4 bullish, 4 bearish.
- IMMP’s TA Score: 4 bullish, 4 bearish.
Price Growth
HIND (@Biotechnology) experienced а -12.99% price change this week, while IMMP (@Biotechnology) price change was +16.89% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
HIND is expected to report earnings on Nov 13, 2026.
IMMP is expected to report earnings on Dec 02, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
HIND and
Correlation & Price change
A.I.dvisor indicates that over the last year, HIND has been loosely correlated with IMMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then IMMP could also see price increases.
| Ticker / NAME | Correlation To HIND | 1D Price Change % | ||
|---|---|---|---|---|
| HIND | 100% | -3.14% | ||
| IMMP - HIND | 36% Loosely correlated | -8.95% | ||
| CLDX - HIND | 32% Poorly correlated | -1.89% | ||
| CABA - HIND | 30% Poorly correlated | -3.33% | ||
| PHAT - HIND | 30% Poorly correlated | +2.16% | ||
| HURA - HIND | 30% Poorly correlated | -9.04% | ||
More | ||||
IMMP and
Correlation & Price change
A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with ELOX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then ELOX could also see price increases.
| Ticker / NAME | Correlation To IMMP | 1D Price Change % | ||
|---|---|---|---|---|
| IMMP | 100% | -8.95% | ||
| ELOX - IMMP | 47% Loosely correlated | -4.52% | ||
| GPCR - IMMP | 38% Loosely correlated | +1.49% | ||
| BCRX - IMMP | 38% Loosely correlated | -1.31% | ||
| HIND - IMMP | 36% Loosely correlated | -3.14% | ||
| LIMN - IMMP | 34% Loosely correlated | +2.59% | ||
More | ||||